#Vascular Graft Market size

[willyskristina]

Embolic Protection Devices Market

Embolic Protection Devices Market Size, Share, Trends: Medtronic plc Leads

Rising Adoption of TAVR Procedures Drives Demand for Embolic Protection

Market Overview:

The Embolic Protection Devices Market is projected to grow at a CAGR of 8.2% from 2024 to 2031. North America currently dominates the market, with the highest market share and revenue. Key metrics include the increasing prevalence of cardiovascular diseases, growing adoption of minimally invasive procedures, and technological advancements in embolic protection devices. The market is experiencing significant growth due to the rising incidence of cardiovascular and neurovascular diseases globally. Embolic protection devices play a crucial role in preventing complications during endovascular procedures, driving their adoption in healthcare settings. The increasing geriatric population and the growing demand for effective treatment options for vascular diseases are also contributing to market expansion.

DOWNLOAD FREE SAMPLE

Market Trends:

A significant trend driving the embolic protection devices market is the rising adoption of transcatheter aortic valve replacement (TAVR) procedures. TAVR has emerged as a minimally invasive alternative to traditional open-heart surgery for treating severe aortic stenosis, particularly in high-risk patients. As TAVR procedures gain popularity, the demand for embolic protection devices has surged to mitigate the risk of periprocedural stroke and other embolic complications. The growing acceptance of TAVR among patients and healthcare providers, supported by expanding indications for its use in lower-risk patients, has led to substantial increases in procedure volumes worldwide.

Market Segmentation:

Distal filter devices currently hold the largest market share in the embolic protection devices segment. These devices are widely preferred due to their ability to capture and remove embolic debris while maintaining blood flow during endovascular procedures. Their versatility across various applications, including carotid artery stenting, saphenous vein graft interventions, and TAVR, contributes to their dominance. Recent advancements in distal filter technology, such as improved capture efficiency and lower crossing profiles, have enhanced their performance and ease of use. Industry leaders such as Boston Scientific Corporation and Medtronic plc have reported significant growth in their embolic protection portfolios, driven by the strong performance of their distal filter devices.

Market Key Players:

The embolic protection devices market is highly competitive, with major players focusing on technological innovation and strategic alliances. Key companies such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Cardinal Health, Inc., Silk Road Medical, Inc., and W. L. Gore & Associates, Inc. are at the forefront, driving innovation and setting trends in the market. These firms invest heavily in R&D to introduce advanced embolic protection devices tailored to the needs of healthcare providers.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[marketsndata]

Global Vascular Access Devices Market Assessment 2031

Global vascular access devices market is projected to witness a CAGR of 5.83% during the forecast period 2024-2031, growing from USD 3.63 billion in 2023 to USD 5.71 billion in 2031. With increasing disease burden, rising hospitalization, and an improved healthcare system, the market of vascular access devices is anticipated to expand at a notable pace during the forecast period.

Vascular access devices are insertions used to administer drugs, fluids, blood, and nutrients in blood vessels. These devices include peripherally inserted central catheters (PICCs), central venous catheters, implantable ports, and peripheral intravenous catheters (PIVCs). With the never-ending evolution of healthcare services and medical devices, vascular access devices have evolved in terms of design, material, and integration of imaging technologies in it. Advancements in vascular access devices have improved biocompatibility, flexibility, and the adoption of novel materials, enhancing patient outcomes and quality of life. The rising demand for vascular access devices is driven by the growing burden of lifestyle diseases, technological advancements, and the need for minimally invasive procedures. Manufacturers are consistently working to enhance device design and materials to improve patient outcomes and reduce complications.

For instance, in May 2024, Teleflex Incorporated launched the Arrow EZ-IO Intraosseous Access Procedure Tray, enhancing its intraosseous vascular access portfolio. It includes all necessary components for intraosseous access, featuring the first FDA-cleared battery-powered driver that can be utilized in sterile environments. The tray is designed for quick and precise insertion, addressing the challenges clinicians face in obtaining vascular access during emergencies. However, risks associated with long-term use of catheters, such as infections and sepsis may pose challenges for market growth.

Rising Burden of Chronic Diseases to Increase the Market Size

The chronic disease burden is on a rise globally, owing to the increasing prevalence of chronic diseases, such as cancer, cardiovascular and urological disorders, and others, which necessitates frequent and long-term vascular access for treatments such as chemotherapy, dialysis, and medication administration, thereby driving the demand for various types of vascular access devices, including central venous catheters and peripheral IV catheters. Another factor contributing to the growing burden is the rising geriatric population, highly prone to catching such diseases. With the ongoing scenario, the future demand for vascular access devices is anticipated to increase further.

For instance, the National Institute of Health (NIH), anticipates that the number of adults 50 years and older suffer from at least one chronic disease, which will increase by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. An estimated 48 million people, or 47% of all deaths globally, are expected to die from severe health-related suffering by 2060, an 87% increase from 26 million in 2016. It is anticipated that 83% of these deaths will occur in low and middle-income countries. As per World Health Organization (WHO) estimates, by 2050, there will be twice as many people 60 years or older on the planet with the population of 2.1 billion.

Design Improvements to Drive Market Demand

The established types of vascular access devices include central venous catheters (CVCs), arteriovenous fistulas (AVFs), and arteriovenous grafts (AVGs). Innovations in CVC tip and coating design have improved patency and blood flow rates. AVFs are preferred over CVCs as they are less prone to clotting and infection while providing reliable and adequate blood flow rates. With such design enhancements, the AVF creation devices have significant traction leading to market growth. Market players are taking chances to launch innovative products with enhanced designs. For instance, in September 2023, Laminate Medical Technologies announced that it received US-FDA clearance for its VasQ External Vascular Support device, designed to create AVFs for dialysis access. Notably, 80% of patients in trials using VasQ were able to remove central venous catheters within their first year of treatment, reducing the risk of infection compared to traditional AVFs. The VasQ device provides structural reinforcement to the vessels during AVF creation, promoting better arterial flow and functionality.

Drug Administration Application to Dominate Vascular Access Devices Market Share

The drug administration application of the vascular access devices market is anticipated to cover the highest market share. As these devices provide reliable, long-term access to the bloodstream, which is essential for patients needing frequent or prolonged intravenous therapies, such as chemotherapy or chronic disease management, reducing complications associated with traditional IV lines, such as infections and vein irritation, by minimizing the need for repeated needle sticks. A recent study published in the British Medical Journal in July 2024 examined the effectiveness of vascular access devices (VADs) in reducing infection rates among hospitalized patients. The study concluded that VADs along with specific safety measures reduce the chances of infection.

Download Free Sample Report

North America Dominates the Global Vascular Access Devices Market Share

North America is anticipated to hold major market share of the global vascular access devices market. North America’s leadership in the demand for vascular access devices is attributed to its advanced healthcare infrastructure, rising prevalence of chronic diseases, technological innovations, supportive regulations, and demographic trends favoring increased healthcare needs. According to the United States Renal Data System 2023 Annual Data Report, published in April 2024, more than 85% of individuals who began hemodialysis used a catheter. Additionally, nearly three-quarters of the United States population started without permanent access, a significant increase from about 65% in 2018. This rise in number clearly shows an increasing consumption of such devices in North America causing it to hold the largest market share among other regions.

Future Market Scenario (2024 – 2031F)

The vascular access devices market has witnessed several remarkable futuristic advancements that are anticipated to shape the future of such devices. These advancements include wearable technology, remote monitoring of atrioventricular flow, use of biocompatible materials for product design, 3D printing technology, image-guided vascular access devices, and others. The USFDA approval of WavelinQ and Ellipsys, two vascular access devices that facilitate the creation of arteriovenous fistulas (AVFs) using minimally invasive techniques has paved a new path for more products in line with endovascular fistula creation. The of the most revolutionary advancement is the image-guided vascular access system, Ultreon 1.0 launched by Abbott in October 2023. This platform uses near-infrared light to provide high-definition, precise imaging from within the blood vessels, allowing the healthcare professional precise access to blood vessels even in the most complex anatomies.

Report Scope

“Vascular Access Devices Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global vascular access devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Click here for full report- https://www.marketsandata.com/industry-reports/vascular-access-devices-market

Latest reports-

Contact

Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: info@marketsandata.com Website: https://www.marketsandata.com

[stanleyhuds]

Vascular Grafts Market Size, Share, Demand, Growth, and Forecast 2025-2033

Global Vascular Grafts Industry: Key Statistics and Insights in 2025-2033

Summary:

The global vascular grafts market size reached USD 2.0 Billion in 2024.

The market is expected to reach 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033.

North America leads the market, accounting for the largest vascular grafts market share.

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

The ongoing technological advancements in graft materials and design are supporting the market growth.

The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

Prevalence of Cardiovascular Diseases:

The rising global cases of cardiovascular diseases (CVDs) are boosting market growth. These diseases often need surgery that uses vascular grafts.

Technological Advancements in Graft Materials and Design:

Technological progress in graft materials and designs is boosting the market. Today's vascular grafts are biocompatible, durable, and reduce complications like infections and rejection. Innovations such as drug-eluting and tissue-engineered grafts are also emerging. These grafts aim to better integrate with the body's tissues. Such advancements improve the safety and effectiveness of vascular surgeries, thus enhancing patient outcomes.

Preference for Minimally Invasive Surgeries (MIS):

Minimally invasive surgeries (MIS) are driving market growth. Procedures like endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) are less invasive than traditional surgeries. They also reduce hospital stays, lower infection risks, and speed up recovery. This boosts interest in specialized vascular grafts for these surgeries. Moreover, patients and doctors are leaning towards MIS for its benefits. This trend increases the demand for compatible vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

Endovascular Stent Grafts

Hemodialysis Access Grafts

Coronary Artery By-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

Polytetrafluoroethylene (PTFE)

Polyester

Polyurethane

Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

Cardiac Aneurysm

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

Hospitals

Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

North America (United States, Canada)

Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: 

Abbott Laboratories

B. Braun SE (B. Braun Holding GmbH & Co. KG)

Becton, Dickinson & Company

Cook Group Incorporated

Cordis

CryoLife Inc.

Getinge AB

Heat Medical Europe BV

LeMaitre Vascular

Medtronic plc

Terumo Corporation

W.L. Gore & Associates Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 

[farmacuticals]

Competitive Landscape and Major Players in the Global Cardiovascular Prosthetic Device Market

Cardiovascular prosthetic devices are specialized medical implants designed to support or replace damaged heart valves, arteries, or other components of the cardiovascular system. These devices play a critical role in the treatment of heart-related conditions, helping improve the quality of life for patients suffering from diseases such as coronary artery disease, heart failure, and valvular heart disease. Common cardiovascular prosthetic devices include artificial heart valves, vascular grafts, stents, and pacemakers.

The Cardiovascular Prosthetic Device Market Size was projected by MRFR research to reach 67.49 (USD Billion) by 2022. It is anticipated that the market for cardiovascular prosthetic devices would increase from 70.68 billion USD in 2023 to 107.2 billion USD in 2032. Over the projected period (2024 - 2032), the Cardiovascular Prosthetic Device Market is expected to develop at a compound annual growth rate (CAGR) of about 4.73%.

The demand for cardiovascular prosthetic devices is driven by the increasing prevalence of cardiovascular diseases worldwide, attributed to factors such as aging populations, sedentary lifestyles, and unhealthy diets. These devices have significantly evolved, with advancements in biocompatible materials, minimally invasive surgical techniques, and improved long-term performance, contributing to better patient outcomes.

Cardiovascular Prosthetic Device Size

The market size for cardiovascular prosthetic devices is substantial and continues to grow at a rapid pace. In 2023, the global cardiovascular prosthetic device market was valued at several billion dollars and is projected to maintain a steady growth rate over the coming years. This growth is fueled by the rising incidence of heart diseases, increasing healthcare spending, and the adoption of advanced medical technologies.

The market is segmented into different types of cardiovascular prosthetic devices, such as heart valves, stents, pacemakers, and ventricular assist devices (VADs). Each segment has its own market size, with heart valves and stents being among the most dominant segments due to their high demand in the treatment of valve disorders and coronary artery diseases. Furthermore, the advent of minimally invasive procedures like transcatheter aortic valve replacement (TAVR) has expanded the market by offering alternatives to traditional open-heart surgery.

Cardiovascular Prosthetic Device Market Share

The cardiovascular prosthetic device market is highly competitive, with several leading companies holding significant market share. Key players include Medtronic, Abbott Laboratories, Edwards Lifesciences, and Boston Scientific. These companies are constantly investing in research and development to introduce innovative products that address unmet medical needs.

Medtronic, for instance, holds a major market share due to its wide range of cardiovascular prosthetic devices, including artificial heart valves and stents. Edwards Lifesciences is a leading player in the heart valve segment, particularly with its transcatheter heart valve products. Abbott Laboratories and Boston Scientific are also strong contenders in the stent and pacemaker markets.

Cardiovascular Prosthetic Device Trends

Several trends are shaping the cardiovascular prosthetic device market, including:

Minimally Invasive Surgeries: There is a growing preference for minimally invasive procedures such as TAVR and transcatheter mitral valve replacement (TMVR), which reduce recovery times and surgical risks for patients.

Biodegradable Stents: The development of bioresorbable stents is revolutionizing coronary artery treatment. These stents dissolve naturally after performing their function, reducing the risk of long-term complications.

Smart Implants: Technological advancements are driving the creation of smart cardiovascular prosthetic devices, such as pacemakers with remote monitoring capabilities, allowing real-time tracking of patient health.

Aging Population: With the aging global population, the demand for cardiovascular prosthetic devices is expected to increase, as elderly individuals are more prone to heart diseases.

Emerging Markets: The cardiovascular prosthetic device market is experiencing growth in emerging economies due to improving healthcare infrastructure, increased awareness, and rising healthcare spending.

Reasons to Buy the Reports

In-Depth Market Analysis: A comprehensive understanding of the current cardiovascular prosthetic device market size, share, and growth trends.

Competitive Landscape: Insights into key players, their market strategies, and the latest product innovations.

Future Market Projections: Detailed forecasts of the market growth and the factors influencing this expansion.

Technological Advancements: Information on the latest technological developments in cardiovascular prosthetic devices and how they are improving patient outcomes.

Regulatory Insights: Key regulatory guidelines and approvals that influence the cardiovascular prosthetic device market, ensuring compliance and market access.

Recent Developments in Cardiovascular Prosthetic Devices

Recent developments in the cardiovascular prosthetic device market include the introduction of next-generation transcatheter valves, bioresorbable stents, and advanced pacemakers with enhanced battery life and wireless connectivity. Moreover, collaborations between medical device companies and research institutions are leading to innovations in the design and functionality of prosthetic devices, focusing on improving patient safety and treatment efficacy. These advancements are expected to drive the growth of the cardiovascular prosthetic device market in the coming years.

Related Report:

Medical Clothing Market

Medical Kiosk Market

Molecular Quality Control Market

[credenceresearchdotblog]

The Vascular Grafts Market is projected to grow from USD 1,263.48 million in 2023 to an estimated USD 2,422.39 million by 2032, with a compound annual growth rate (CAGR) of 7.50% from 2024 to 2032. The global vascular grafts market has seen significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the aging population, and advancements in medical technology. Vascular grafts are used in surgical procedures to bypass, repair, or replace damaged blood vessels, making them a crucial component in the treatment of various vascular conditions. These grafts can be synthetic, biological, or composite, depending on the material used, and they play a critical role in procedures such as coronary artery bypass surgery, peripheral artery disease treatment, and hemodialysis access.

Browse the full report at https://www.credenceresearch.com/report/vascular-grafts-market

Market Overview

As of 2024, the vascular grafts market is experiencing a robust growth trajectory, with a market value that is expected to reach billions of dollars in the coming years. The demand for vascular grafts is fueled by the increasing burden of cardiovascular diseases, which are among the leading causes of death globally. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) claim over 17 million lives annually, and this number is expected to rise due to factors such as unhealthy lifestyles, rising obesity rates, and an aging population.

The market is segmented based on product type, application, and end-user. The main types of vascular grafts include:

1. Endovascular Stent Grafts – Used in minimally invasive procedures to treat aneurysms or occluded blood vessels. 2. Peripheral Vascular Grafts – Typically used to bypass or replace damaged vessels in the peripheral arterial system. 3. Hemodialysis Access Grafts – Commonly used to create arteriovenous (AV) fistulas for patients undergoing dialysis.

Key Drivers of Market Growth

1. Rising Prevalence of Cardiovascular Diseases The increasing incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, is the primary driver of the vascular grafts market. As lifestyles become more sedentary, coupled with poor dietary habits and rising levels of obesity, the demand for cardiovascular procedures such as coronary artery bypass grafting (CABG) is rising.

2. Aging Population The global population is aging, and older adults are more prone to cardiovascular diseases, atherosclerosis, and related complications. This demographic trend is a major factor contributing to the growth of the vascular grafts market. Elderly individuals often require vascular grafts in procedures such as aneurysm repair or dialysis access creation, which boosts demand.

3. Technological Advancements The development of new materials and technologies for vascular grafts has significantly enhanced their performance and outcomes. For instance, the introduction of bioengineered grafts and hybrid materials that combine synthetic and biological properties has improved the compatibility and durability of grafts. Furthermore, advancements in endovascular procedures, which are less invasive than traditional open surgeries, have driven the adoption of vascular grafts, particularly stent grafts.

4. Increasing Incidence of End-Stage Renal Disease (ESRD) The rising prevalence of diabetes and hypertension has contributed to a growing number of patients with end-stage renal disease (ESRD). These patients require hemodialysis, and vascular grafts are often used to create AV fistulas for dialysis access. As the incidence of ESRD increases, so does the demand for vascular grafts, particularly in the healthcare sector of developed countries.

Challenges Facing the Market

Despite the promising growth, the vascular grafts market faces several challenges. One major concern is the risk of graft failure due to infection, thrombosis, or rejection. While advances in material science have improved the performance of grafts, complications still arise, particularly in high-risk patients. Additionally, the cost of vascular grafts and associated procedures can be prohibitive for patients in low- and middle-income countries, limiting access to these life-saving interventions.

Another challenge is the stringent regulatory environment that governs the approval and commercialization of vascular grafts. Medical devices, especially those used in critical procedures, are subject to rigorous testing and approval processes. This can delay the introduction of new products to the market.

Regional Insights

The vascular grafts market is segmented by region, with North America, Europe, Asia-Pacific, and the Rest of the World (RoW) being key markets. North America holds the largest share of the market, driven by the high prevalence of cardiovascular diseases, a well-established healthcare system, and the presence of leading medical device manufacturers. Europe follows closely behind, with a similar disease burden and strong healthcare infrastructure.

In contrast, the Asia-Pacific region is expected to witness the fastest growth in the coming years, driven by the increasing healthcare expenditure, a growing middle class, and rising awareness of cardiovascular health. Countries such as China and India are seeing a surge in demand for vascular grafts due to the rising incidence of lifestyle-related diseases and improvements in healthcare accessibility.

Future Outlook

The future of the vascular grafts market looks promising, with continued growth expected due to ongoing advancements in medical technology, an aging population, and the increasing prevalence of cardiovascular diseases. Innovations in graft materials, such as the use of bioresorbable polymers and tissue-engineered grafts, will likely enhance the durability and success rates of vascular procedures.

Moreover, as healthcare systems in emerging economies improve, the demand for vascular grafts in these regions is expected to increase. Government initiatives aimed at improving cardiovascular health and expanding access to healthcare services will also play a crucial role in driving market growth.

Key players

Medtronic

Terumo Corporation

LeMaitre Vascular, Inc.

Getinge AB

BD (Becton Dickinson)

Abbott

Braun Melsungen AG

L. Gore and Associates, Inc.

MicroPort Scientific Corporation

Endologix

Segments

Based on product

Haemodialysis Access Grafts

Endovascular Stent Grafts

Coronary Artery Based on-Pass Grafts

Vascular Grafts for Aorta Disease

Peripheral Vascular Grafts

Based on application

Cardiac Aneurysm

Endovascular Stent Graft

Vascular Graft

Kidney Failure

Vascular Occlusion

Coronary Artery Disease

Others

Based on raw material

Synthetic Vascular Grafts

Polytetrafluoroethylene (PTFE) Grafts

Polyester Grafts,

Polyurethane Grafts

Biological Vascular Grafts

Autografts

Allografts

Xenografts

Hybrid Vascular Grafts

Based on region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/vascular-grafts-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[willyskristina]

Surgical Glue Market

Surgical Glue Market Size, Share, Trends: Johnson & Johnson Leads

Shift Towards Bio-Based and Biodegradable Surgical Adhesives

Market Overview:

The Surgical Glue Market is expected to grow significantly, driven by increasing surgical procedures, the growing prevalence of chronic diseases, and the rising adoption of minimally invasive surgeries. North America stands out as the dominant region, accounting for a substantial share of the global market. The market is expanding rapidly due to technological advances in adhesive compositions and an increased demand for non-invasive closure techniques.

The industry is shifting towards bio-based and biodegradable surgical adhesives, with producers focusing on creating solutions with improved biocompatibility and wound healing capabilities. This trend is primarily driven by increased concerns about the environmental impact of synthetic materials, as well as an increase in demand for biocompatible surgical equipment. 

DOWNLOAD FREE SAMPLE

Market Trends:

The surgical glue market is seeing a considerable transition towards bio-based and biodegradable solutions. This trend is driven by increased concerns about the environmental impact of synthetic materials and the rising demand for biocompatible surgical equipment. Bio-based surgical adhesives provide several advantages, including a lower risk of allergic responses, greater tissue integration, and wound healing characteristics. Bio-based surgical adhesives accounted for a significant portion of the market in 2023, with a predicted CAGR of 9.5% between 2024 and 2031.

Market Segmentation:

Synthetic surgical adhesives dominate the market, accounting for a significant share of the global market. This supremacy is due to their versatility, strong adhesive capabilities, and broad range of applications across various surgical procedures. Synthetic surgical adhesives have several advantages, including quick polymerization, high tensile strength, and the ability to customize to specific tissue types. These factors have contributed to their extensive use in multiple surgical specialties.

The use of synthetic surgical adhesives in cardiovascular surgery has increased significantly, driven by the rising number of coronary artery bypass grafting (CABG) procedures and the adhesives' efficiency in sealing vascular anastomoses. Synthetic surgical adhesives have also gained popularity in neurosurgery, with adoption rates increasing year on year due to their capacity to provide good dural sealing while lowering the danger of cerebrospinal fluid leaks. Recent advances in synthetic surgical adhesive technology have aimed to improve biocompatibility and reduce the risk of tissue irritation, resulting in better tissue integration and fewer long-term issues.

Market Key Players:

Prominent players in the surgical glue market include Johnson & Johnson, Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Medtronic plc, CryoLife, Inc., Cohera Medical, Inc., Adhezion Biomedical, LLC, Chemence Medical, Inc., and Teleflex Incorporated. These companies are leading the market with their innovative approaches, extensive product portfolios, and robust distribution networks, continuously setting industry standards and driving market growth.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[pranalip]

Cardiovascular Devices Market – In Depth Insight Analysis to 2033 | Global Insight Services

“Global Insight Services offers unparalleled market intelligence and strategic consulting services to businesses worldwide. Our expertise spans across various industries, including healthcare, technology, and consumer goods, providing comprehensive analysis and actionable insights. By leveraging advanced data analytics and in-depth market research, we empower our clients to make informed decisions, identify growth opportunities, and stay ahead of the competition”.

The global cardiovascular devices market size was USD 53.3 billion in 2021 and is anticipated to reach USD 91.9 billion in 2031, growing at a rate of 5.2% from 2022 to 2031.

Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Cardiovascular devices such as stents, catheters, grafts, and others are used to treat CVDs efficiently.

View The Full Report Here –https://www.globalinsightservices.com/reports/cardiovascular-devices-market

Market Trends and Drivers

The cardiovascular devices control irregularities caused by the heart’s electrical systems, such as irregular heartbeat and heart rhythm disorders. When medication, lifestyle changes, or other treatments do not work, an implantable device may be recommended. Certain factors that are boosting the cardiovascular devices market growth include a rise in the use of ambulatory and home services for cardiac monitoring, the increasing prevalence of cardiovascular disorders, favorable reimbursement policies, and technological advancements.

Besides, the growth of the global cardiovascular devices market is also attributed to the growing demand for high-performance and efficient cardiovascular systems globally. Increasing awareness regarding the benefits of the cardiovascular devices market is expected to positively impact the revenue growth of the market over the forecast period. In addition, developments in cardiovascular devices positively contribute to the growth of the global cardiovascular devices market. Further, the rising demand for cardiovascular devices from emerging economies to treat patients suffering from cardiovascular devices effectively is expected to cater to the growth of the cardiovascular devices industry. Besides, the rise in the number of hospitals in addition to small and medium-sized companies is increasing the demand for cardiovascular devices. Furthermore, technological advancements in cardiovascular devices are anticipated to offer lucrative opportunities for the market players.

Market Restraints & Challenges

One of the major factors hindering the global cardiovascular devices market growth is the stringent regulatory requirements that delay the approval of cardiac devices. In addition, the other concern & risk connected to the market is that the therapeutic radiation used in cancer treatment affects the operation of a patient with implantable cardiac rhythm devices. This device uses complementary metal-oxide-semiconductor (CMOS) which are susceptible to damage by the therapeutic doses of radiation. This factor is one of the major factors that limits the scope of using cardiac devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. Besides, the high cost of these devices along with limited insurance coverage is restraining the growth of the market.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now-https://www.globalinsightservices.com/request-sample/GIS20313

Market Segments

By Type

Diagnostic & Monitoring Devices

Therapeutic & Surgical Devices

By Application

Cardiac Rhythm Management & Heart Failure

Coronary Vascular

Structural Heart

Peripheral Vascular

Others

By End User

Hospitals

Specialty Centers

Major Players of the Global Cardiovascular devices Market

The global cardiovascular devices market report includes players such as Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Cook Medical, Koninklijke Philips N.V., Medtronic plc., and Terumo Corporation.

Prominent players in the industry such as Abbott Laboratories, Boston Scientific Corp., and Medtronic plc. are focusing on adopting acquisition as their key developmental strategy to boost the product offerings of cardiovascular devices. For instance, in February 2022, Boston Scientific acquired Baylis Medical Company Inc., which offers advanced transseptal access solutions along with guidewires, sheaths, and dilators used to support catheter-based left-heart procedures.

COVID-19 Analysis:

According to the International Monetary Fund (IMF), due to the epidemic of a novel coronavirus, the worldwide economy decreased by over 3.0% in 2020. Several nations were under strict lockdowns in 2020 & 2021, which have impacted the supply of raw materials. Therefore, due to this, the manufacturing activities of cardiovascular device producers have ceased. While some cardiovascular procedures are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. The other aspect negatively affecting the market is the drop in the diagnosis of cardiovascular diseases owing to healthcare resources being reserved for COVID-19 patients. Besides, several medical device companies have suffered losses in their cardiovascular device businesses owing to the pandemic. To cite an instance, Medtronic plc announced a reduction of nearly one-third in its cardiac and vascular business sector in its 2020 quarterly financial results. Moreover, demand for cardiovascular devices from hospitals has been dropped amid their stopped operations, due to government-imposed lockdown measures. This is anticipated to hamper the cardiovascular devices market growth during the forecast period.

Buy Now@https://www.globalinsightservices.com/checkout/single_user/GIS20313

 Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions

In-depth segmentation which can be customized as per your requirements

Free consultation with lead analyst of the report

Infographic excel data pack, easy to analyze big data

Robust and transparent research methodology

Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1-833-761-1700 Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.